Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens by Cerqueira, J. et al.
Specific Configuration of Dendritic
Degeneration in Pyramidal Neurons of the
Medial Prefrontal Cortex Induced by
Differing Corticosteroid Regimens
Joa˜o J. Cerqueira1, Ricardo Taipa1, Harry B.M. Uylings2,
Osborne F.X. Almeida3 and Nuno Sousa1
1Life and Health Sciences Research Institute (Instituto de
Investigacxa˜o em cieˆncias da vida e da sau´de), School of
Health Sciences, University of Minho, Campus de Gualtar, 4710-
057 Braga, Portugal, 2Netherlands Institute for Brain Research,
Graduate School Neurosciences Amsterdam, Royal Netherlands
Academy of Arts and Sciences, 1105 AZ Amsterdam, The
Netherlands and 3Neuroadaptations Group, Max Planck Institute
of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany
We previously demonstrated that hypercorticalism induces pro-
nounced volumetric reductions in the rat medial prefrontal cortex
(mPFC) and that these structural changes correlate with deficits in
executive function. By applying 3-dimensional analysis of Golgi-
Cox--stained material, we now demonstrate that corticosteroids
can exert differential effects on dendritic arborizations of pyramidal
neurons in lamina II/III of the mPFC. Treatment with the glucocor-
ticoid receptor--selective agonist dexamethasone and with the
natural adrenosteroid, corticosterone (CORT), results in significant
reductions in the total length of apical dendrites in the pyramidal
neurons in lamina II/III of the anterior cingulate/prelimbic and
infralimbic cortices. Interestingly, although these treatments do not
affect the number of dendritic branches, they are associated with
impoverished arborizations in their distal portions and, in CORT-
treated animals, with increased branching in the middle portions of
the apical dendritic tree. Deprivation of corticosteroids by adrenal-
ectomy leads to decreases in total apical dendritic length and spine
number, but in this case, dendritic impoverishment was restricted
to the middle/proximal segments of the dendritic trees. None of
the treatments influenced the architecture of the basal dendrites.
These results add to our knowledge of the morphological sub-
strates through which corticosteroids may disrupt mPFC-dependent
behaviors.
Keywords: adrenalectomy, cingulate cortex, corticosteroid,
dendritic morphology, stress
Introduction
Prefrontal cortex (PFC) dysfunction is a hallmark of several
psychiatric disorders, and a number of studies have implicated
functional and structural abnormalities in this region as a prob-
able basis of cognitive impairment in schizophrenia and mood
disorders (Rajkowska 2000; Rauch et al. 2003; Ballmaier et al.
2004; Lewis et al. 2004; Rogers et al. 2004; Shad et al. 2004;
Yamasue et al. 2004; Cullen et al. 2006; Nugent et al. 2006).
Stress is a major contributor to the etiology, pathophysiology,
and treatment outcome of mood and affective disorders, and
corticosteroids released in response to stress have been causally
linked to psychopathology. Both chronic stress and disturban-
ces in the homeostatic mechanisms that regulate corticosteroid
secretion are known to affect the structure and function of the
rat medial prefrontal cortex (mPFC) (Mizoguchi et al. 2000,
2004; Wellman 2001; Coburn-Litvak et al. 2003; Cook and
Wellman 2004; Radley et al. 2004, 2005; Roozendaal et al.
2004; Cerqueira, Catania, et al. 2005; Cerqueira, Pego, et al.
2005). Among others, the structural changes include volumetric
reductions (Cerqueira, Catania, et al. 2005; Cerqueira, Pego,
et al. 2005) in the most superﬁcial layers and dendritic
remodeling of pyramidal cells located in layer II/III of the
mPFC (Cook and Wellman 2004; Radley et al. 2004, 2005).
Corticosteroid actions in the brain are mediated by mineralo-
corticoid (MR) and glucocorticoid (GR) receptors (de Kloet
et al. 2005). The mPFC contains both MR and GR (Chao et al.
1989; Patel et al. 2000; Herman et al. 2005) that become
activated by stress (Cullinan et al. 1995; Figueiredo et al.
2003) and contribute to the neural control of the endocrine
response and behavioral adaptation to stress (Diorio et al. 1993;
Sullivan and Gratton 2002; Mizoguchi et al. 2003; Herman et al.
2005).
We previously showed that differential activation of MR and
GR results in distinct structural rearrangements in the mPFC
(Cerqueira, Pego, et al. 2005), resembling those seen in the
hippocampal formation in several respects (reviewed in
Sousa and Almeida 2002). In Cerqueira, Pego, et al. (2005), we
reported that exposure to the GR-selective agonist dexameth-
asone (DEX) results in signiﬁcant reductions in the volume of
layer II and cell number in layer II pyramidal neurons that are
paralleled by behavioral impairments. Strikingly, the concomi-
tant activation of GR and MR by the physiological adrenosteroid,
corticosterone (CORT), produces only mild cognitive deﬁcits;
this treatment paradigm results in a reduction in the volume of
layer II without inﬂuencing neuronal numbers. In that same
study (Cerqueira, Pego, et al. 2005), we observed deﬁcits in
behavioral ﬂexibility in rats deprived of endogenous cortico-
steroids by adrenalectomy (ADX); the behavioral changes
occurred in the absence of morphological changes in the mPFC.
In an extension of our previous studies, we have now assessed
dendritic morphology in pyramidal layer II/III of ADX rats, in
rats in which GRs were persistently activated through DEX
administration, and in animals experiencing concomitant occu-
pation of MR and GR through exogenous CORT therapy. All
treatments lasted 1 month. Golgi-Cox--stained dendritic trees
(apical and basal arborizations) of pyramidal neurons located
in lamina II/III of the different subdivisions of the mPFC (in-
fralimbic [IL], prelimbic, and cingulate [Cg] cortex regions)
were quantitatively examined by applying 3-dimensional (3D)
morphometry.
Experimental Procedures
Animals and Treatments
Experiments were conducted in accordance with European regulations
(European Union Directive 86/609/EEC) and National Institutes Health
guidelines on animal care and experimentation.
Adult male Wistar rats (Charles River Laboratories, Barcelona, Spain)
were group housed under standard laboratory conditions (lights on
from 8 AM--8 PM, room temperature 22 C, ad libitum access to food and
drink). Treatments were initiated when animals were 8 weeks old and
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continued over a period of 4 weeks. All drugs were from Sigma (St Louis,
MO). To compare the inﬂuence of the corticosteroid milieu, rats were
randomly assigned to one of 4 treatment groups (n = 5), with equal
average weights: 1) Controls (VEH), receiving daily subcutaneous
injections of sesame oil (vehicle), but otherwise maintained as de-
scribed above; 2) Adrenalectomized (ADX, performed under pentobar-
bital anesthesia), receiving daily subcutaneous injections of vehicle and
provided with 0.9% saline as drinking solution; 3) Corticosterone
(CORT) treated, receiving one daily subcutaneous injection of CORT
(25 mg/kg in sesame oil); and 4) DEX treated, receiving a daily
subcutaneous injection of DEX (300 lg/kg dissolved in sesame oil
containing 0.01% ethanol). All injections were administered 1 h before
‘‘lights off.’’ At the end of the experimental period, 22 h after the last
injection, blood (tail venepuncture) samples were collected for basal
measurements of CORT (1 h after ‘‘lights on’’). Serum CORT levels were
subsequently measured by radioimmunoassay (MP Biochemicals, Costa
Mesa, CA).
Histological Procedures
One day after the last injection, rats were transcardially perfused with
0.9% saline under deep pentobarbital anesthesia and processed accord-
ing to the protocol described by Gibb and Kolb (1998). Brieﬂy, brains
were removed and immersed in Golgi--Cox solution (a 1:1 solution of 5%
potassium dichromate and 5% mercuric chloride diluted 4:10 with 5%
potassium chromate—Glaser and Van der Loos 1981) for 14 days; brains
were then transferred to a 30% sucrose solution (minimum 3 days),
before being cut on a vibratome. Coronal sections (200 lm thick) were
collected in 6% sucrose and blotted dry onto cleaned, gelatin-coated
microscope slides. They were subsequently alkalinized in 18.7%
ammonia, developed in Dektol (Kodak), ﬁxed in Kodak Rapid Fix
(prepared as per package instructions with solution B omitted),
dehydrated through a graded series of ethanols, cleared in xylene,
mounted, and coverslipped.
Dendrite Analysis
Pyramidal neurons in layers II--III of the Cg1-3 and IL areas of the mPFC
(Zilles and Wree 1995) were analyzed. Both areas of the mPFC, which
are comparable to prefrontal areas in the primate (Uylings et al. 2003),
are located on the medial wall of the rostral cortex and are readily
identiﬁable: the IL cortex, which lies ventral to area Cg1-3 (i.e., ante-
rior Cg and prelimbic cortices, which are indistinguishable in Golgi-
Cox--stained preparations), is markedly thinner and has fewer, less
well-deﬁned layers (Van Eden and Uylings 1985; Zilles and Wree 1995).
Within the mPFC, layers II--III are readily identiﬁable in Golgi-stained
material on the basis of its characteristic cytoarchitecture. It is
positioned immediately ventral to the relatively cell-poor layer I (which
also contains the distal dendritic tufts of layer II/III pyramidal cells) and
immediately superﬁcial to layer V; this boundary is pronounced because
of the greater cell-packing density and smaller somata of pyramidal cells
in layers II--III relative to layer V in this region of the brain (Van Eden and
Uylings 1985; Cajal 1995; Zilles and Wree 1995).
Golgi-impregnated pyramidal neurons of the mPFC were readily
identiﬁed by their characteristic triangular soma, apical dendrites
extending toward the pial surface, and numerous dendritic spines.
The criteria used to select neurons for reconstruction were those
described by Uylings et al. (1986) and Radley et al. (2004): 1) location of
the cell soma in layer II/III of the mPFC, approximately in the middle
third of the section; 2) full impregnation of the neurons; 3) apical
dendrite without truncated branches (except on the most superﬁcial
layer); 4) presence of at least 3 primary basal dendritic shafts, each of
which branched at least once; and 5) no morphological changes
attributable to incomplete dendritic impregnation of Golgi--Cox stain-
ing. In order to minimize selection bias, slices containing the region of
interest were randomly searched and the ﬁrst 10 neurons fulﬁlling the
above criteria (maximum of 3 neurons per slice) were selected.
For each selected neuron, all branches of the dendritic tree were
reconstructed at 6003 magniﬁcation using a motorized microscope
(Axioplan 2, Carl Zeiss, Germany), with oil objectives, and attached to
a camera (DXC-390, Sony Corporation, Tokyo, Japan) and Neurolucida
software (Microbrightﬁeld, VT). A 3D analysis of the reconstructed neu-
rons was performed using NeuroExplorer software (Microbrightﬁeld).
Forty neurons were studied for each animal of the 4 experimental
groups, and neurons from the same animal were averaged. Several
aspects of dendritic morphology were examined. To assess overall
changes, total length of basal and apical trees and number of basal
dendrites and apical dendritic branches were compared across groups
using 1-way analysis of variance (ANOVA) (Uylings and van Pelt 2002).
To assess differences in the arrangement of dendritic material, a 3D
version of a Sholl analysis (Sholl 1956; Uylings and van Pelt 2002) was
performed. For this, we counted the number of intersections of
dendrites with concentric spheres positioned at radial intervals of 20
lm; in addition, we also measured the length of the dendritic tree
located between 2 consecutive spheres.
The method for sampling dendritic branches for spine density (i.e.,
spines per micron dendritic length) was designed as follows: only
branches that 1) were either parallel or at acute angles to the coronal
surface of the section and 2) did not show overlap with other branches
that would obscure visualization of spines were considered. Because
treatment-induced changes in the apical dendritic branches varied with
distance to soma, segments were randomly selected in the proximal (Cg:
140--200 lm; IL: 60--120 lm) and distal (Cg: 240--300 lm; IL: 140 lm--200
lm) parts of the tree, where maximal effects were observed; basal
dendrites selectionwas done at radial distances between 50 and 100 lm.
In Golgi-impregnated material, the spines emerging toward the
surface or directly into the section are not well visualized. Thus, to
minimize bias, only spines that emerged perpendicular to the dendritic
shaft were counted. Furthermore, an attempt to correct for hidden
spines (Feldman and Peters 1979) was not made because the use of
visible spine counts for comparison between different experimental
conditions had been validated previously (Horner and Arbuthnott
1991). To assess treatment-induced changes in spine morphology,
spines in the selected segments were classiﬁed according to Harris
et al. (1992) in mushroom, thin, wide, and ramiﬁed categories and the
proportion of spines in each category compared using 1-way ANOVA.
Statistics
All data were compared using 1-way ANOVA followed by appropriate
post hoc comparisons using Tukey’s honestly signiﬁcant differences
(HSDs) test. Sholl analysis data were compared across groups using 1-
way repeated measures ANOVA (group 3 distance from soma) followed
by post hoc comparisons (Tukey’s HSD). Differences were considered
to be signiﬁcant if P < 0.05.
Results
Serum CORT Levels
The steroid treatment protocols resulted in the following serum
CORT level (CONTROLS [CONT]: 45.3 ± 12.0 ng/mL; CORT:
283.6 ± 22.6 ng/mL; DEX: nondetectable; ADX: nondetectable).
Anterior Cg and Prelimbic Cortices (Cg1-3)
All treatments produced signiﬁcant reductions in total length of
apical dendrites of pyramidal cells in layer II/III of the anterior
Cg and prelimbic areas (i.e., Cg1-3) (F3,16 = 7.509, P = 0.002;
CONT: 2100.0 ± 88.6 lm; CORT: 1384.9 ± 138.6 lm [less 34%],
P = 0.004; DEX: 1476.5 ± 108.7 lm [less 30%], P = 0.012; ADX:
1434.0 ± 146.3 lm [less 32%], P = 0.007) without affecting the
total number of apical branches per neuron (F3,16 = 0.128, P =
0.942; CONT: 20.25 ± 1.63; CORT: 19.83 ± 1.85; DEX: 19.57 ±
1.33; ADX: 18.88 ± 1.58) (Fig. 1). Sholl analysis of apical dendritic
segment lengths and the number of intersections as a function
of their distance from the soma revealed an overall effect of
treatment (length: F3,16 = 7.834, P = 0.002; intersections: F3,16 =
4.888, P = 0.013) (Fig. 2). CORT animals had increased
branching in the middle portions of the tree, whereas both
DEX- and CORT-treated rats showed a marked reduction of
dendritic material at distances greater than 280 lm from the
soma when compared with controls (length—CORT: P = 0.003,
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DEX: P = 0.017; intersections—CORT: P = 0.045, DEX: P =
0.022). ADX led to a signiﬁcant reduction of dendritic material
at distances between 140 and 220 lm from the soma (length: P =
0.004, intersections: P = 0.030) but did not affect distal portions
of the tree. This reorganization of the dendritic material at the
apical dendrites is exempliﬁed in Figures 3 and 4 that illustrate
neurons typically seen in each of the 4 treatment groups.
Despite this reorganization, treatments failed to affect the
average spine density (proximal—F3,16 = 0.886, P = 0.469, CONT:
1.08 ± 0.04 spines/lm, CORT: 1.02 ± 0.10 spines/lm, DEX:
0.93 ± 0.06 spines/lm, ADX: 0.98 ± 0.07 spines/lm; distal—
F3,16 = 1.717, P = 0.204, CONT: 0.66 ± 0.05 spines/lm, CORT:
0.78 ± 0.02 spines/lm, DEX: 0.76 ± 0.04 spines/lm, ADX: 0.72 ±
0.04 spines/lm) (Fig. 1) and the proportion of spines of each
morphological category in both proximal and distal segments
of the apical dendritic tree (proximal—mushroom: F3,16 = 1.994,
P = 0.156; thin: F3,16 = 0.399, P = 0.756; wide: F3,16 = 0.351,
P = 0.789; ramiﬁed: F3,16 = 0.661, P = 0.588; distal—mushroom:
F3,16 = 0.711, P = 0.560; thin: F3,16 = 0.409, P = 0.749; wide: F3,16 =
0.990, P = 0.423; ramiﬁed: F3,16 = 0.569, P = 0.644). (Fig. 5)
Treatment did not exert a signiﬁcant effect on basal dendritic
trees (number: F3,16 = 0.992, P = 0.422, CONT: 5.75 ± 0.53,
CORT: 4.83 ± 0.23, DEX: 5.00 ± 0.15, ADX: 5.50 ± 0.36; length:
F3,16 =0.416,P=0.744,CONT: 2071.8±196.8lm,CORT: 1997.3±
81.1 lm, DEX: 1990.0 ± 145.0 lm, ADX: 2001.9 ± 142.6 lm;
spine density: F3,16 = 2.145, P = 0.135, CONT: 0.97 ± 0.05 lm,
CORT: 0.72 ± 0.07 lm, DEX: 0.78 ± 0.10 lm, ADX: 0.87 ± 0.07
lm; spine types—mushroom: F3,16 = 0.956, P = 0.437; thin: F3,16 =
2.105, P = 0.140; wide: F3,16 = 1.884, P = 0.173; ramiﬁed: F3,16 =
0.980, P = 0.427) (Figs 1 and 5). Sholl analysis of the distribution
of basal dendritic material as a function of its distance from the
soma did not reveal any between-group differences (length:
F3,16 = 1.107, P = 0.375; intersections: F3,16 = 0.738, P = 0.545)
(data not shown).
Figure 1. Morphometric analysis of apical dendrites in the mPFC. Note the selective shrinkage of the apical dendrites induced by all treatments. Mean (±standard error of mean)
total length, branch number, and spine densities in Cg1-3 and IL apical (A, B, E, F) and basal (C, D, G, H) dendrites in layer II/III pyramidal cells. The experiment included 4 treatment
groups: VEH—controls (injected with vehicle); CORT—corticosterone-treated group; DEXA—dexamethasone-treated rats; ADX—adrenalectomized animals (injected with
vehicle). All treatments lasted 4 weeks and commenced when rats were 8 weeks old. *P\ 0.05 versus VEH.
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Infralimbic Cortex
The total length of apical dendrites of pyramidal cells of layer III
of the IL was signiﬁcantly reduced by all treatments (F3,16 =
10.725; P < 0.001; CONT: 1492 ± 105.2 lm; CORT: 1154 ± 112.0
lm [less 23%], P = 0.049; DEX: 825 ± 53.0 lm [less 47%], P <
0.001; ADX: 1119 ± 38.0 lm [less 25%], P = 0.028); however, the
total number of apical branches was not affected by any of the
treatments (F3,16 = 0.391, P = 0.76, CONT: 27.40 ± 3.37, CORT:
24.71 ± 3.54, DEX: 25.42 ± 2.74, ADX: 29.00 ± 2.70) (Fig. 1). Sholl
analysis of apical dendritic segment lengths and of the number
of intersections as a function of their distance from the soma
revealed an overall effect of treatment (length: F3,16 = 9.141, P =
0.001; intersections: F3,16 = 4.878, P = 0.014) (Fig. 2). DEX- and
CORT-treated rats showed marked reductions of dendritic
material at distances greater than 160 lm from the soma
when compared with controls (length—CORT: P = 0.02, DEX:
P = 0.001; intersections—CORT: P = 0.045, DEX: P = 0.020). ADX
was accompanied by a reduction of dendritic material between
60 and 120 lm from the soma (length: P = 0.008, intersections:
P = 0.033), but there was no effect on the distal portions of the
apical dendritic tree.
Average spine density (proximal—F3,16 = 2.032, P = 0.150,
CONT: 0.87 ± 0.08 spines/lm, CORT: 0.88 ± 0.05 spines/lm,
DEX: 1.09 ± 0.08 spines/lm, ADX: 0.97 ± 0.07 spines/lm; distal—
F3,16 = 0.139, P = 0.935, CONT: 0.96 ± 0.09 spines/lm, CORT:
0.91 ± 0.10 spines/lm, DEX: 0.98 ± 0.07 spines/lm, ADX: 0.94 ±
0.04 spines/lm) (Fig. 1) and the proportion of spine of each
morphological category in both proximal and distal segments of
the apical dendritic tree were not affected by any treatment
(proximal—mushroom: F3,16 = 1.628, P = 0.222; thin: F3,16 =
1.916, P = 0.168; wide: F3,16 = 0.532, P = 0.667; ramiﬁed: F3,16 =
0.384, P = 0.776; distal—mushroom: F3,16 = 0.257, P = 0.855; thin:
F3,16 = 0.887, P = 0.469; wide: F3,16 = 2.049, P = 0.148; ramiﬁed:
F3,16 = 1.000, P = 0.418). (Fig. 5)
Figure 2. Differential rearrangements of apical dendrites in the mPFC after cortico-
steroids and ADX. Sholl analysis-derived distribution of mPFC layer II/III pyramidal cell
apical dendritic material based on distance from cell body. (A, C) Mean length of apical
dendrite branches between consecutive 20-lm-spaced concentric spheres of Cg--
prelimbic (Cg1-3) and IL regions. (B, D) Mean number of intersections of apical
dendrite branches with consecutive 20-lm-spaced concentric spheres of Cg--prelimbic
and IL regions. See Figure 1 for treatment details. *P\ 0.05 versus VEH. Means and
standard error of mean are plotted.
Figure 3. Photomicrographs of neurons of area Cg1-3. Representative examples from
VEH-, CORT-, DEX-, and ADX-treated rats (A--D, respectively) are shown. Scale bar
represents 200 lm. See Figure 1 for treatment details.
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Treatment did not exert a signiﬁcant effect on basal dendritic
trees (number: F3,16 = 0.713, P = 0.558, CONT: 4.80 ± 0.37,
CORT: 4.50 ± 0.50, DEX: 4.00 ± 0.32, ADX: 4.60 ± 0.40; length:
F3,16 = 0.329, P = 0.804, CONT: 1026.1 ± 66.73 lm, CORT: 971.4
± 85.21 lm, DEX: 1079.1 ± 92.51 lm, ADX: 962.7 ± 123.16 lm;
spine density: F3,16 = 0.708, P = 0.561, CONT: 0.90 ± 0.05 spines/
lm, CORT: 0.93 ± 0.06 spines/lm, DEX: 0.97 ± 0.10 spines/lm,
ADX: 1.05 ± 0.09 spines/lm, spine types—mushroom: F3,16 =
0.384, P = 0.766; thin: F3,16 = 1.510, P = 0.250; wide: F3,16 = 1.890,
P = 0.172; ramiﬁed: F3,16 = 0.616, P = 0.614) (Figs 1 and 5). Sholl
analysis of the distribution of basal dendritic material as
a function of its distance from the soma failed to reveal any
between-group differences (length: F3,16 = 0.070, P = 0.975;
intersections: F3,16 = 0.879, P = 0.473) (data not shown).
Discussion
In an attempt to analyze how stress, acting through the
mediation of corticosteroids, might induce structural changes
in the mPFC, we here carried out a detailed morphometric
analysis of dendritic architecture in Golgi-Cox--stained prepa-
rations. One principal ﬁnding was that chronic administration of
corticosteroids selectively induces morphological rearrange-
ments in the apical dendrites of layer II/III pyramidal neurons
without affecting the structure of basal dendrites. These
alterations led to an overall remodeling of the pattern of
dendritic branching: whereas the number of dendritic branches
per neuron was not reduced, corticosteroid treatment led to an
increase of dendritic branching in the proximal-to-medial
portions of the apical dendrite and, concomitantly, signiﬁcant
reductions in dendritic arborization at the distal portions. With
the exception of our present observation that corticosteroids
induce signiﬁcant reductions in the total length of the apical
dendrites, our results are consistent with a previous report
(Wellman 2001). In an extension of the earlier studies, the
experimental design used in this work allowed us to delineate
the impact of speciﬁc alterations in the corticosteroid milieu in
the neuropil of the mPFC.
The selective vulnerability of apical dendrites tomanipulations
of the corticosteroid milieu, as reported here and by others (see
Wellman 2001; Radley et al. 2004; Brown et al. 2005), is
particularly interesting. It most likely reﬂects the topographical
distribution of inputs to layer II/III pyramidal cells of the PFC:
whereas the soma and basal dendritic tree are innervated by
thalamic projections (Shibata 1993), afferents from limbic
structures, including the hippocampus, terminate in the super-
ﬁcial layers (Swanson andCowan1977), thusmakingpreferential
contact with apical dendrites. Furthermore, although both the
limbic and thalamic ﬁber systems are glutamatergic, their post-
synaptic actions are primarily mediated by ionotropic N-methyl-
D-Aspartate (NMDA) receptors (Rudolf et al. 1996) and metabo-
tropic (a-amino-5-hydroxy-3-methyl-4-isoxazole propionic acid
[AMPA]) receptors (Pirot et al. 1994), respectively. Interestingly,
a study addressing the expression of NMDA receptors in the rat
PFC (Rudolf et al. 1996) has shown that mPFC layer II, where the
apical dendrites of pyramidal neurons are located, is more richly
endowed with NMDA.R2B-containing receptors than other
layers of the same cortex. Importantly, it has been shown that
NMDA.R2B plays a crucial role in corticosteroid-induced ex-
citotoxicity (Lu et al. 2003). In contrast, AMPA receptors that
transduce thalamic-to-PFC signals are clustered in the basal
dendrites and soma and are scarcely localized at the apical
dendrite (Vickers et al. 1993); when activated, AMPA receptors
can protect neurons against glutamate-induced neurotoxicity
(Wu et al. 2004) by stimulating the expression of brain-derived
growth factor (Lauterborn et al. 2000).
The pattern of dendritic reorganization observed after
sustained exposure to high levels of corticosteroids is compa-
rable with that found in the hippocampal formation (Watanabe
et al. 1992; Magarinos et al. 1998; Sousa et al. 1999). Stress-
induced apical dendritic atrophy in the hippocampus (CA3
area) was shown to be mediated by glutamate release and sub-
sequent NMDA, but not AMPA receptor, activation (Magarinos
and McEwen 1995). It is important to emphasize that the stress
response cannot be exclusively attributed to elevated CORT
levels, but reports that stress, through the mediatory actions of
corticosteroids, can stimulate glutamate release in the mPFC
(Takita et al. 2002) strongly suggest that the morphological
adjustments observed in the hippocampus and mPFC may be
underpinned by similar pathways. Importantly, however, there
are other nonexclusive mechanisms putatively implicated in
hypercorticalism-induced dendritic atrophy. In fact, it was
recently shown that chronic CORT treatment decreases brain-
derived neurotrophic factor expression in the PFC (Dwivedi
et al. 2006), suggesting that lack of trophic support might
also contribute to the herein-observed changes. Another pos-
sible mechanism involves corticosteroid-mediated changes in
Figure 4. Computer assisted reconstructions of representative neurons. Illustrated
are neurons in each of 3 orthogonal planes (XY, YZ, XZ) in the Cg1-3 area from VEH-,
CORT-, DEX-, and ADX-treated rats (A--D, respectively). See Figure 1 for treatment
details.
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cytoskeletal proteins because it was previously shown that
activation of GR receptors induces changes in the phosphory-
lation and conformational pattern of the cytoskeletal protein,
tau (Green et al. 2006). In addition, altered calcium currents
(McEwen 2000), changes in neuronal cell adhesion molecules
(Sandi 2004), and serotoninergic neuromodulatory activity
(Conrad et al. 1996; Stutzmann et al. 1998) are also likely to
play a prominent role.
Irrespectively of the underlying mechanisms, what might be
the functional consequences of stress- or corticosteroid-
induced dendritic atrophy in the mPFC? We previously pro-
posed that the structural reorganization that occurs in the
hippocampus following chronic stress may serve an adaptive
purpose insofar that it would counteract excessive excitatory
inputs that would constrain the eventual regrowth of dendrites
and spines upon cessation of the stressor (Sousa and Almeida
2002). A recent report describing the reversibility of stress-
induced dendritic plasticity in the mPFC (Radley et al. 2005)
suggests that, as in the hippocampus (Sousa et al. 2000), apical
dendrite retraction in the mPFC is likely to be of adaptive value.
Atrophy of the PFC and parallel deﬁcits in working memory
are commonly found in posttraumatic stress disorder (Rauch
et al. 2003), depression (Rajkowska 2000; Rogers et al. 2004),
and schizophrenia (Lewis et al. 2004; Shad et al. 2004; Yamasue
Figure 5. Morphological classification of dendritic spines. (A) High-magnification photomicrograph to exemplify the morphological categories used to classify dendritic spines.
Mushroom—single arrow; Thin—double arrow; Wide—arrow head; Ramified—thick arrow. Scale bar represents 10 lm. (B--G) Mean (±standard error of mean) proportion of
dendritic spines of each morphological category in Cg1-3 and IL apical (B, C, E, F) and basal (D, G) dendritic trees. See Figure 1 for treatment details.
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et al. 2004); a substantial proportion of patients suffering from
these conditions also show dysregulation of endocrine response
(corticosteroid secretion) to stress (Altamura et al. 1999;
Barden 2004; Ryan et al. 2004). Because the PFC participates
in the homeostatic control of corticosteroid secretion (Diorio
et al. 1993; Sullivan and Gratton 2002; Mizoguchi et al. 2003)
and corticosteroids can, in turn, have profound effects upon
PFC-dependent functions (Coburn-Litvak et al. 2003; Roozen-
daal et al. 2004), it is plausible that corticosteroid-induced
atrophy in the PFC feeds into a vicious circle.
Our recent neuroimaging (Cerqueira, Catania, et al. 2005) and
histological (Cerqueira, Pego, et al. 2005) studies demonstrated
that prolonged administration of the GR agonist DEX causes
selective neurodegeneration of the superﬁcial layers of all PFC
areas. The results of the present study suggest that those
observations of volumetric atrophy in the most superﬁcial layers
of the mPFC likely result from the reorganization of apical
dendrites of layer II/III pyramidal neurons. One of those earlier
studies (Cerqueira, Pego, et al. 2005) also showed that DEX, but
not CORT (the natural corticosteroid that displays afﬁnity for
both MR and GR), induced neuronal loss in the mPFC and that
DEX treatment produced signiﬁcantly greater cognitive impair-
ment than CORT treatment. As CORT and DEX do not differ
signiﬁcantly in their ability to induce atrophy among the apical
dendrites of layer II/III pyramidal neurons, it may be inferred
that the herein-observed neuropil changes are mediated by GR;
importantly, the further cognitive deterioration produced by
DEX should be attributed to the neuronal death-inducing
properties of exclusive GR activation, as previously shown in
the hippocampus (Sousa et al. 1999).
In this study, we also found that treatment with either CORT
or DEX failed to affect the average spine density in 2 distinct
regions of the apical dendritic tree of layer II/III pyramidal
neurons. Because both treatments resulted in striking reduc-
tions of total dendritic length, it is plausible to admit that
corticosteroid imbalances lead to decreased total spine number.
However, the validity of this assumption must be regarded with
care as it might be inﬂuenced by 2 factors: 1) because spine
densities vary across different portions of the apical dendritic
arbor of mPFC pyramidal neurons (Radley et al. 2006), use of
randomly selected segments in 2 different regions of the tree
might not allow for a generalization of densities in the entire
apical dendritic tree; 2) Golgi impregnation techniques assess
almost exclusively spines emerging perpendicular to the
dendritic shaft and parallel to the plane of the section. As
a consequence of the latter, our estimation of spine densities in
prefrontal cortical pyramidal neurons is signiﬁcantly lower (3--4
times) than those obtained with more robust techniques such
as 3D reconstruction using confocal (Radley et al. 2006) or
serial electron microscopy imaging (Elston et al. 2005); impor-
tantly, however, our estimations were of equal magnitude as
those obtained by others using a similar approach (Seib and
Wellman 2003; Silva-Gomez et al. 2003; Murmu et al. 2006).
These technical issues are relevant to understand some of the
discrepant observations in the literature regarding spine density
in mPFC pyramidal neurons after stress and corticosteroid
treatment. Indeed, a previous study using CORT (Seib and
Wellman 2003) reported an increased spine density in the
proximal region of the dendritic tree (a region endowed with
few spines), but not in thedistal segments,wherewe also failed to
observe differences. In contrast, in chronic stressmodels, despite
different technical approaches, others (Silva-Gomez et al. 2003;
Radley et al. 2006) found a reduction of spine density in
prefrontal pyramidal cells, thus reinforcing the view that, besides
technical differences, stress exposure triggers othermechanisms
besides elevations of circulating levels of corticosteroids.
This study also sought to identify the structural correlates of
impaired performance by corticosteroid-deprived (ADX) ani-
mals on tasks (e.g., behavioral ﬂexibility) that depend on the
PFC (Mizoguchi et al. 2004; Cerqueira, Pego, et al. 2005).
Whereas we did not detect ADX-induced volumetric changes
or neuronal losses in our previous work (Cerqueira, Catania,
et al. 2005; Cerqueira, Pego, et al. 2005), we here observed that
ADX has signiﬁcant effects on the morphology of apical
dendrites in pyramidal layers II/III of the mPFC: ADX rats
display decreased branching in the middle third of the dendritic
tree (at radial distances, relative to the soma, 120--240 lm in
Cg1-3 and 60--120 lm in IL), despite preserved branching
patterns at higher radial distances. The topologically different im-
poverishments observed in ADX versus corticosteroid-treated
animals suggest mediation through distinct neurochemical
substrates. One important difference between these experi-
mental conditions relies on the glutamatergic system in the PFC:
whereas in states of hypercorticalism there is activation of
glutamatergic transmission (Takita et al. 2002), ADX is known to
reduce glutamate release in the PFC (Moghaddam et al. 1994).
Given the putative role of glutamate-mediated excitotoxicity in
the neurodegenerative changes herein reported, it is plausible
to admit that such differences could contribute for the topo-
graphically distinct actions of ADX compared with DEX and
CORT treatment.
Altered dopaminergic transmission could also plausibly ac-
count for the ADX-induced effects. This hypothesis is based on
the following observations: ADX impairs PFC-dependent tasks
through a hypodopaminergic status mediated by D1 receptors
(Mizoguchi et al. 2000) that show a preferential localization to
the proximal portions of the apical dendrite of pyramidal cells in
the PFC (Bergson et al. 1995) and whose ablation results in
structural changes in the apical dendrites of PFC pyramidal cells
(Stanwood et al. 2005). However, because chronic stress can
also induce hypodopaminergia (Mizoguchi et al. 2000), the
latter alternative should be considered with caution. Another
plausible, and not necessarily mutually exclusive, explanation
for the difference in neuropil changes between ADX versus
CORT-/DEX-treated animals is a lack of trophic support in ADX
rats resulting from a process of deafferentation (Mizrahi and
Libersat 2002), given the well-known ADX-induced hippocam-
pal degeneration (Sloviter et al. 1989; Sousa et al. 1997).
Without implicating direct clinical relevance, some remarks
on the link of the present work to certain disorders may be
warranted: 1) schizophrenic patients display a decrease in the
thalamo-PFC projections that terminate on the middle layers of
the PFC (Lewis et al. 2001), a phenomenon associated with
selective atrophy of basal dendritic trees (Shibata 1993) and 2)
given the fact that inappropriate adrenocortical activity may be
causally related to PFC dysfunction in depressive conditions, we
propose that depressed patients most likely display changes in
the PFC neuropil that closely resemble those observed in
animals treated with corticosteroids.
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